Greg Sempowski

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter

Filter by Publication Type

Search Results

Nebulized mRNA-encoded antibodies protect hamsters from SARS-CoV-2 infection

An epitope-enriched immunogen expands responses to a conserved viral site

An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy

Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection

A virion-based combination vaccine protects against influenza and SARS-CoV-2 disease in mice

Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion

STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant

SARS-CoV-2 reinfection across a spectrum of immunological states

Structural diversity of the SARS-CoV-2 Omicron spike

Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation

Early age-related atrophy of cutaneous lymph nodes precipitates an early functional decline in skin immunity in mice with aging

Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials

Meningococcal detoxified outer membrane vesicle vaccines enhance gonococcal clearance in a murine infection model

Cervicovaginal microbiota predicts neisseria gonorrhoeae clinical presentation

SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice